← back to database
NLVC is a technology-centric venture capital firm that invests globally in early-stage enterprise, healthcare, and consumer technology companies. Founded in 2005, they focus on businesses driving digital transformation, scientific innovation in healthcare, and new consumer experiences. Their approach, "Founders Backing Founders," leverages the operational and technical expertise of their experienced team to support entrepreneurs with disruptive potential. NLVC has backed over 400 companies since its inception, with a particular emphasis on early-stage technology ventures.
B2B / B2C
Investment style
Generalist
Data last enriched
Aug 14, 2026
Investing team
- Feng DengFounding Managing Partner
- He HuangPartner
- Stella LiPartner
- Jeffrey D. LeePartner
- Lu LinPartner
- Pandy SongPartner
- Tony WuPartner
- Fiona YuPartner
- Figo ZhangPartner
- Jing ChenSenior Associate
- Chen LijiSenior Associate
- Charlie ChenExecutive Director
- Kirk ZhengjieAssociate
- Yang HuaSenior Associate
- Yan KeVenture Partner
- Shuai LiSenior Associate
- Lixin LiVenture Partner
- Kehong LyuAnalyst
- Qing PengVice President
- Zhi TanVenture Partner
- Howard WangSenior Associate
- Ning XuAssociate
- Yu TuoSenior Associate
- Jiagang ZhangAssociate
- Chuck ZhangAnalyst
- Alice ZhangSenior Associate
- Simon ZhaoExecutive Director
Notable investments
Carta, Qumulo, Stellar Cyber, Cytek Biosciences, Immune-Onc Therapeutics, Applied Cells, ZERO&